Integration lets frameworks talk to each other through middleware. Convergence brings them under the same architecture, which can can reduce costs and maintenance.
- What Europe's Draft Annex 22 Actually Asks Of Human Oversight Of AI
- How To Keep Your 'Big Bang' Platform Switch From Becoming A Big Bust
- Fine-Tuning Bioseparation Column Geometry With 3D-Printed Monoliths
- How Is Your Glass Supplier Adapting To Europe's Energy Crisis?
- The EU Overhauls Pharma Laws: What You Need To Know
- Can Peptide Mapping Predict Intact Antibody PTM Distributions?
- How To Stand Up A Hospital-Based CAR-T Manufacturing Network
EDITOR'S DESK
-
On The Ground At BPI: Jacqualyn Schulman, Ph.D., On Accelerating Clonal CLD
An interview with Jacqualyn Schulman, Ph.D., a principal scientist at Bristol Myers Squibb (BMS), on her presentation at BPI 2026, “Fast-Tracking CHO Cell Line Development Using Integrated Engineering Strategies.”
This article captures key takeaways from a BioProcess International keynote by Preeya Boppana, director of MSAT process analytics and laboratories at AstraZeneca, titled “Transforming Biologics Manufacturing: Leveraging Predictive Analytics and Advanced Process Control for Next-Generation Operations.”
Regulatory compliance and cGMP manufacturing expert Tatyana Matveeva, Ph.D., explains the role and importance of a quality unit in an organization, as well as what happens when it’s compromised.
Experts discuss where productivity gains can be achieved and how development teams should seek to improve process performance in this recap of the Bioprocess Online Live event "The Levers And Tradeoffs That Drive Process Productivity."
Siren Biotechnology's SVP of vector development, Nathalie Clément, Ph.D., explains the challenge of purifying AAV capsids and the ways developers are optimizing vector recovery.
GUEST COLUMNISTS
-
What Europe's Draft Annex 22 Actually Asks Of Human Oversight Of AI
The European Commission and the Pharmaceutical Inspection Co-operation Scheme (PIC/S) consulted on draft Annex 22, Artificial Intelligence. Here's what you should know.
-
How To Keep Your 'Big Bang' Platform Switch From Becoming A Big Bust
Leaders at a Roche fill/finish facility describe the tactile steps involve to change EMS, ERP, and WMS all at once with no rollback option.
-
How Is Your Glass Supplier Adapting To Europe's Energy Crisis?
Europe's glass manufacturers, including those making pharmaceutical lab glassware, have experienced a series of energy shocks. Many have adopted sustainability practices.
-
Fine-Tuning Bioseparation Column Geometry With 3D-Printed Monoliths
If geometric control, not retention, is the priority in viral vector separation, research group says high-resolution 3D-printing chromatography monoliths can be useful.
-
The EU Overhauls Pharma Laws: What You Need To Know
On Sept. 18, the Council of the EU published the almost-final text of a major overhaul of the EU pharmaceutical laws. The final binding text is expected to be published very soon.
-
Can Peptide Mapping Predict Intact Antibody PTM Distributions?
Peptide mapping quantifies modification at individual sites, but the same site-level results can correspond to different distributions across intact molecules.
-
How To Stand Up A Hospital-Based CAR-T Manufacturing Network
Estimates show that a small hospital-based, modular GMP facility can deliver more than 250 products per year with more flexibility than fully automated, integrated equipment.
-
Closing The CAR-T Access Gap With Hospital-Based Manufacturing
Improvements in closed-loop processing and lower material costs could bring distributed manufacturing within reach. Hospitals still need to stand up production suites.
BIOPROCESSING WHITE PAPERS
-
Sample-Attribute-Based Selection Strategies For AAV %Full Determination
AAV %Full analysis must distinguish full, empty, and partial capsids, with complementary methods selected according to sample characteristics, analytical needs, development stage, and context.
-
Leveraging Digitalization To Resolve CGT Manufacturing Challenges2/12/2025
Uncover digitalization's role in overcoming manufacturing challenges in cell and gene therapies to enhance efficiency, quality, and scalability through data analytics and real-time monitoring.
-
Stabilization Of RNA-Loaded Lipid Nanoparticles By Lyophilization8/15/2025
Discover how lyophilization enhances RNA-based therapeutics by enabling storage at higher temperatures, which simplifies cold-chain logistics while preserving nanoparticle integrity and biological activity.
-
ADCs As Biological Missiles For Targeted Therapies6/15/2026
Antibody-drug conjugates are reshaping cancer treatment. Learn how monoclonal antibody targeting, linker design, and next-gen payloads are defining the future of precision oncology.
-
Providing Enhanced Manufacturing Data To Contracting Companies2/12/2025
The life sciences sector is projected to reach $220 billion by 2030. Examine the growth of CDMOs and CMOs, emphasizing the need for digitalization to meet client demands and regulatory standards.
-
Excellence In Peptide And Oligonucleotide Purification11/5/2025
Explore how digital tools are advancing peptide purification, with a focus on GLP-1 receptor agonists, as well as how process efficiency can be accelerated through real-time insights.
BIOPROCESSING APP NOTES & CASE STUDIES
- Evaluating Carryover When Using A TOC Analyzer
- Elevating Downstream Process Development With Real-Time Data Monitoring
- De-Risking Drug Development: Informatics-Supported Solid Form Selection
- A Duplex Assay For Quantification And Qualification Of AAV
- Maximizing MSC Yield And Quality: A Comparative Media Study
- On The Ground At BPI: Where AI Dreams Meet Operational Reality
- On The Ground At BPI: Tatyana Matveeva, Ph.D., On Distributed Manufacturing Models
- Contextualizing Data To Enable AI And Prevent Knowledge Leaks
- On The Ground At BPI: Jacqualyn Schulman, Ph.D., On Accelerating Clonal CLD
- AstraZeneca's Focus On Predictive Control, Semi-Autonomous Processing
- Prioritizing Quality Over Everything
- Evaluating The Levers Driving Productivity In Bioprocessing
EDITORIAL COLLECTIONS KNOWLEDGE CENTER
Editorial Collections are subscriber-only, curated resources that combine expert interviews, feature articles, and industry analysis to help readers better understand emerging trends, operational challenges, regulatory developments, and best practices shaping the biopharma industry.
More Editorial CollectionsFEATURED PRODUCTS AND SERVICES
ON-DEMAND WEBINARS
- The Critical Role Of Integrated Handling Design
- Decoding Biologic Performance: Combining SPR And Cell-Based Assays To Drive Development Decisions
- Rethinking Facility Design For The Reality Of Complex Biologics
- How Automation Can Facilitate Annex 1 Compliance In Final Filtration
- From Blind Spots To Insights: Real-Time Monitoring Of Stem Cell Biology
INDUSTRY NEWS
NEWSLETTER ARCHIVE
- 11.09.26 -- Building A Fill-Finish Strategy That Lasts
- 11.09.26 -- Critical Decisions Driving Next-Generation Cell Line Development
- 11.06.26 -- New Podcast Episodes: AI And Digital Twins In Bioprocessing, Tomorrow's CNS Breakthroughs, Advancing CGT Delivery
- 11.06.26 -- On The Ground At BPI: Tatyana Matveeva, Ph.D., On Distributed Manufacturing Models
- 11.06.26 -- Building Sustainable Biopharma Supply Chains Starts With Procurement

